look at my 3 last posts - 1 of which was posted after your
look at my 3 last posts - 1 of which was posted after your post
Besides impatience so common to pennies,most recent posters are laboring under incomplete info or ignorance re the various approaches NNLX is using.
Trading assumes the 11-27-17 mentioned NSF app was filed by dec4 and since we've not heard of an award that that failed and so all is lost. my logic just posted indicated that NSF app will be filed by the new July deadline.
there are at least 3 categories of progress/action
1) internal growth confirmed in updates which eventually will reach the magic net income by itself,growing over 400% yoy in the last posted financials.
2)But as NNLX updates have noted in the last year NNLX is not satisfied by the RELATIVELY slow internal growth-that thinking alone detailed in updates late last year should have longs thrilled bc that thinking is a gamechanger itself
So there are three grant apps now!!!
3). And the new approach to either partner or license or sell the flat pack patent in certain geographic areas including the huge EU and Chinese markets.
thats 3 approaches right there, "partner or license or sell".
License is imo more likely in the short term bc of the difficulty of discounting (determining) future earned income of a new product vs income of the current product used by those companies. Partnerships are more complicated than licensing.
There is no reason to believe that the interest by maybe a dozen parties in 7 or more countries is limited to a response to an email sent by NNLX- i dont know where that idea came from-with that kind of thinking man would not have invented fire yet.
Limited human thinking never fails to amaze me. I'm 50 years ahead of the competition in my many fields of expertise. Science is not one of those fields but logic is and professors would fall out of their chairs and say you understand in minutes what it takes a semester to teach. Science is not even 1 of my top 1000 fields and i dont even have an intuitive understanding of the products since i dont work in a lab and this board is outside of my comfort zone but a few of us were working hard to make this site a viable alternative to the basher boards for the benefit of the many
but i guess just as businessmen and lawyers and scientists all use different languages due to the destructive effects of uber specialization, that must explain why some of the posting businessmen and most of those w scientific bents dont understand NNLX game changing moves in the last year.
but i guess thats what i should expect by those who believe they evolved from an amoeba when the earth never even had a prebiotic soup and even if the earth did the odds against the simplest life form would/ve been 1 in a number so huge( w 24 million zeros) that it would be scientifically impossible.
1
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...
Continue Reading
Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...
Continue Reading
AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...
Continue Reading
Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...
Continue Reading
AI Reshapes the Agency Paradigm Nobody saw this coming a decade ago, but here we are—AI's taking the wheel, but with humans still riding shotgun. The agency world, particularly the one dealing with e-commerce giants like Amazon, Walmart, and Target, has flipped on its head. Ave7® steps up as the frontrunner, adapting faster than a broker's reflex after a market bell....
Continue Reading
An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...
Continue Reading
A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....
Continue Reading
Innovation in Cooling: Panduit's Latest Move You hear "AI" and "data center" together and you know it's not gonna be business as usual. Here's Panduit throwing another log on the fire with their newly minted AI Cooling Lab. Panduit's a big cheese in the electrical and network infrastructure world. They've taken their Thermal Lab, given it a face-lift, and now, they’re...
Continue Reading
Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...
Continue Reading
OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...
Continue Reading
Top 5 Most Recently Viewed Articles
Investors Show Confidence in Dell Technologies In recent trading sessions, significant investors have adopted a bullish approach to Dell Technologies (NYSE: DELL). Such movements usually signal investor confidence and the possibility of future price movements. Interestingly, options trading data we've analyzed indicates that this activity stemmed from large transactions,...
Continue Reading
Community Heritage Financial Completes Subordinated Debt Offering Community Heritage Financial, Inc. (OTC PK: CMHF), parent company of Middletown Valley Bank, has successfully executed a private placement of subordinated debt, amounting to a substantial $12.1 million. This offering of 6.75% Fixed-to-Floating Rate Subordinated Notes, due 2034, reflects the Company’s...
Continue Reading
Understanding Evolent Health's Market Position Recently, analysts at Barclays have reaffirmed their positive outlook on Evolent Health (NYSE: EVH), maintaining an Overweight rating and a price target of $39.00. This confidence comes in light of discussions surrounding the impacts of Humana's recent struggles with Medicare Star ratings. The management team at Evolent,...
Continue Reading
Revolutionizing the Luxury Furniture Game In the world of luxury furnishings, where every curve and finish sends a message, Caracole is making a bold move to streamline its operations. They're throwing the confetti for Centric PLM, a platform that's set to oust the scattered chaos of spreadsheets and emails. And let me tell you, for any investor eyeing the luxury home...
Continue Reading
Join Us for RaySearch Laboratories' Year-End Report Presentation Analysts, investors, and media representatives are cordially invited to a detailed presentation focused on RaySearch Laboratories' Year-end report for the year 2024. Details of the Presentation Set for February 21, 2025, at 10:00 AM CET, the report will be made accessible to attendees starting at 07:45 AM on...
Continue Reading